Aarti Drugs Limited Financial Ratios
AARTIDRUGS · Healthcare · Current price ₹396
P/E ratio
18.5x
P/B ratio
2.6x
ROE
12.6%
ROCE
11.5%
Debt / Equity
0.37
Dividend yield
0.5%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 18.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.6x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 12.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 11.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.37 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Aarti Drugs Limited's latest numbers.
Aarti Drugs Limited profitability
Aarti Drugs Limited generates a return on equity of 12.6% and a return on capital employed of 11.5%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.37 and a P/E of 18.5x, Aarti Drugs Limited is conservatively financed. Our overall business-quality score for the company is 4.0 / 10.
Understand the ratios
More on Aarti Drugs Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.